tiprankstipranks
Trending News
More News >

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. AGM Resolutions Approved

Story Highlights
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. AGM Resolutions Approved

Don’t Miss TipRanks’ Half-Year Sale

The latest update is out from YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ).

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. successfully held its Annual General Meeting (AGM) on May 29, 2025, where all proposed resolutions were approved by shareholders. The resolutions included the approval of the company’s financial statements and reports for the year ended December 31, 2024, and the re-appointment of KPMG as the company’s auditor. The approval of these resolutions reflects strong shareholder support and positions the company for continued stability and growth.

The most recent analyst rating on (HK:1558) stock is a Buy with a HK$13.80 price target. To see the full list of analyst forecasts on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H stock, see the HK:1558 Stock Forecast page.

More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a pharmaceutical company based in the People’s Republic of China. The company is involved in the production and distribution of pharmaceutical products, focusing on providing healthcare solutions.

Average Trading Volume: 6,545,967

Technical Sentiment Signal: Buy

Current Market Cap: HK$13.09B

See more insights into 1558 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1